By Filippa Lentzos, Guy Reeves, September 18, 2020 A worker conducts testing during the 2014 Ebola outbreak in Liberia. Once a COVID-19 vaccine is approved for public use, officials around the world will face the monumental challenge of vaccinating billions of people, a logistical operation rife with thorny ethical questions. What if instead of orchestrating complicated and resource-intensive campaigns...
By Sally Robertson, B.Sc.Sep 16 2020 Researchers in the United States have described the effectiveness of a candidate monoclonal antibody currently being evaluated in a Phase 1 trial as a therapy for coronavirus disease 2019 (COVID-19) and its causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The drug, called CPI-006, targets an immune signaling molecule...
Results of a recent research endeavor from the United States indicate that bromelain or bromelain rich pineapple stem may be utilized as an antiviral agent against coronavirus disease (COVID-19), but also for potential future coronavirus outbreaks. This exciting paper is currently available on the bioRxiv* preprint server. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is already well-known for...
by Kelsey Simpkins, University of Colorado at Boulder Singing indoors, unmasked can swiftly spread COVID-19 via microscopic airborne particles known as aerosols, confirms a new peer-reviewed study of a March choir rehearsal which became one of the nation’s first superspreading events. “This study documents in great detail that the only plausible explanation for this superspreading event...
EUROPEAN LUNG FOUNDATION IMAGE: CT SCAN OF PATIENT’S LUNGS SHOWING COVID-19 DAMAGE IN RED. COVID-19 patients can suffer long-term lung and heart damage but, for many, this tends to improve over time, according to the first, prospective follow-up of patients infected with the coronavirus, presented at the European Respiratory Society International Congress. [1] Researchers in...
UT SOUTHWESTERN MEDICAL CENTER IMAGE: FIT KITS ALLOW PATIENTS TO MAIL IN STOOL SAMPLES TO SCREEN FOR COLON CANCER. DALLAS – Sept. 8, 2020 – A program that asks patients to mail in stool samples to screen for colon cancer is an effective way to expand screenings to underserved and underinsured communities and offers an...
By Dr. Sanchari Sinha Dutta, Ph.D.Sep 8 2020 A recent study demonstrates that functional CD4+ and CD8+ T cells specifically targeting the entire proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain active in individuals who have recovered from severe or mild coronavirus disease 2019 (COVID-19). Moreover, the magnitude of T cell response is correlated with the...
More than a quarter of American adults are experiencing COVID-related symptoms of depression, researchers report. Though 8.5% of adults were experiencing depression symptoms before the pandemic, the rate climbed to 27.8% of adults by mid-April 2020. “Depression in the general population after prior large-scale traumatic events has been observed to, at most, double,” says Sandro...
AUGUST 28TH, 2020 MEDGADGET EDITORS OTC, PUBLIC HEALTH Since the COVID-19 pandemic began, companies around the world have been working on solutions to improve how the world responds to the crisis. LG, the giant South Korean electronics manufacturer, has just announced that it has developed a face mask that is an air purifier that cleans...
By Dr. Liji Thomas, MD The global pandemic of COVID-19 continues to cause thousands of deaths and many hundreds of thousands of new infections every day. New methods are urgently needed to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and manage them better, including developing criteria for hospitalization. A new study by a...
